Having joined Osborne Clarke in 2007, there’s little doubt about Silvia’s specialism – she has devoted her entire career to life sciences and healthcare.
Today, Silvia applies that wealth of knowledge to her role. In doing so, she has worked with a wealth of high-profile clients, both nationally and internationally, including a long-term relationship with one of the world leaders in plasma-based products.
An expert in commercial law, Silvia is often called on for her advisory skills in commercial transactions, as well as regulatory issues around clinical trials, R&D activities and market access. In each instance, her approach is collaborative – in a sector which is evolving rapidly, Silvia works in close co-ordination with every client, keeping pace with change as it happens.
During her career Silvia has also gained considerable experience and skill in Corporate Compliance, with a particular focus in anticorruption related matters.
New medical devices regulation gains approval in Spain
What the Whistleblowing Directive means for reporting channels in corporate groups
Whistleblower protection law approved by Spain's Congress
The catalogue of crimes that can be committed by legal entities in Spain is expanded
Spain approves draft law to strengthen protection for whistleblowers
Whistleblowing Directive reopens the debate on whether to outsource reporting channels
Impact of the Ukraine war on contract performance: force majeure?
Compassionate Use in Europe
Patient support programs: comments on Royal Decree 957/2020
Are European advertising laws ready for patient support programmes?
How to minimize corruption and bribery risks when hiring a third party
There are different laws (FCPA, UK Bribery Act, the Spanish Criminal Code, to mention some) that set out the possibility...